Literature DB >> 23138265

Three cases of IgG4-related orbital inflammation presented as unilateral pseudotumor and review of the literature.

Tomoki Origuchi1, Hiroki Yano, Hideki Nakamura, Akiyoshi Hirano, Atsushi Kawakami.   

Abstract

IgG4-related disease is an emerging disease entity characterized by elevated serum IgG4 concentration and tumefaction or tissue infiltration by IgG4-positive plasma cells. In IgG4-related disease, tumor-like lesions develop in multiple organs, such as the lacrimal gland, salivary gland, lung, pancreas, kidney, and lymph nodes. We report here three cases of IgG4-related orbital inflammation that presented as unilateral pseudotumors. The patients all were men, with an age range of 65-75 years. The patients had been pointed out unilateral intra-orbital masses, and histopathological examinations revealed marked accumulation of IgG4-positive plasma cells (IgG4/IgG ratio: 51.1-71.6%) with fibrosis. But storiform fibrosis was seen in only one case, and no obliterative phlebitis was seen. The serum levels of IgG4 were increased to 178-670 mg/dL. The masses had well-defined homogeneous signal intensities, and they were hypo-intense on T1-weighted MR images and iso-intense on T2-weighted MR images. Gadolinium enhanced mass lesions in two cases. All orbital mass lesions responded well to corticosteroid treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23138265     DOI: 10.1007/s00296-012-2566-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

Review 1.  Inflammatory pseudotumor.

Authors:  Lakshmana Das Narla; Beverley Newman; Stephanie S Spottswood; Shireesha Narla; Rajasekhar Kolli
Journal:  Radiographics       Date:  2003 May-Jun       Impact factor: 5.333

Review 2.  IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement.

Authors:  Zachary S Wallace; Arezou Khosroshahi; Frederick A Jakobiec; Vikram Deshpande; Mark P Hatton; Jill Ritter; Judith A Ferry; John H Stone
Journal:  Surv Ophthalmol       Date:  2011-10-21       Impact factor: 6.048

3.  Radiological features of IgG4-related disease in the head, neck, and brain.

Authors:  Masaki Katsura; Harushi Mori; Akira Kunimatsu; Hiroki Sasaki; Osamu Abe; Toru Machida; Kuni Ohtomo
Journal:  Neuroradiology       Date:  2012-02-23       Impact factor: 2.804

4.  Orbital inflammation in IgG4-related sclerosing disease.

Authors:  Theodore Pasquali; Lynn Schoenfield; Steven J Spalding; Arun D Singh
Journal:  Orbit       Date:  2011-10

5.  Clinical and pathological differences between Mikulicz's disease and Sjögren's syndrome.

Authors:  M Yamamoto; S Harada; M Ohara; C Suzuki; Y Naishiro; H Yamamoto; H Takahashi; K Imai
Journal:  Rheumatology (Oxford)       Date:  2004-10-27       Impact factor: 7.580

6.  Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.

Authors:  Y Masaki; L Dong; N Kurose; K Kitagawa; Y Morikawa; M Yamamoto; H Takahashi; Y Shinomura; K Imai; T Saeki; A Azumi; S Nakada; E Sugiyama; S Matsui; T Origuchi; S Nishiyama; I Nishimori; T Nojima; K Yamada; M Kawano; Y Zen; M Kaneko; K Miyazaki; K Tsubota; K Eguchi; K Tomoda; T Sawaki; T Kawanami; M Tanaka; T Fukushima; S Sugai; H Umehara
Journal:  Ann Rheum Dis       Date:  2008-08-13       Impact factor: 19.103

7.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

8.  Gastric inflammatory pseudotumor in children.

Authors:  C K Maves; J F Johnson; K Bove; R L Malott
Journal:  Radiology       Date:  1989-11       Impact factor: 11.105

Review 9.  A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details.

Authors:  Hisanori Umehara; Kazuichi Okazaki; Yasufumi Masaki; Mitsuhiro Kawano; Motohisa Yamamoto; Takako Saeki; Shoko Matsui; Takayuki Sumida; Tsuneyo Mimori; Yoshiya Tanaka; Kazuo Tsubota; Tadashi Yoshino; Shigeyuki Kawa; Ritsuro Suzuki; Tsutomu Takegami; Naohisa Tomosugi; Nozomu Kurose; Yasuhito Ishigaki; Atsushi Azumi; Masaru Kojima; Shigeo Nakamura; Dai Inoue
Journal:  Mod Rheumatol       Date:  2011-09-01       Impact factor: 3.023

10.  Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease.

Authors:  Yasufumi Masaki; Nozomu Kurose; Motohisa Yamamoto; Hiroki Takahashi; Takako Saeki; Atsushi Azumi; Shinji Nakada; Shoko Matsui; Tomoki Origuchi; Susumu Nishiyama; Kazunori Yamada; Mitsuhiro Kawano; Akira Hirabayashi; Keita Fujikawa; Tomoko Sugiura; Masanobu Horikoshi; Naoto Umeda; Hiroshi Minato; Takuji Nakamura; Haruka Iwao; Akio Nakajima; Miyuki Miki; Tomoyuki Sakai; Toshioki Sawaki; Takafumi Kawanami; Yoshimasa Fujita; Masao Tanaka; Toshihiro Fukushima; Katumi Eguchi; Susumu Sugai; Hisanori Umehara
Journal:  Int J Rheumatol       Date:  2012-05-10
View more
  4 in total

Review 1.  IgG4-Related Ophthalmic Disease: Pooling of Published Cases and Literature Review.

Authors:  Albert Wu; Nicholas H Andrew; Alan A McNab; Dinesh Selva
Journal:  Curr Allergy Asthma Rep       Date:  2015-06       Impact factor: 4.806

Review 2.  Immunoglobulin G4-related diseases in the head and neck: a systematic review.

Authors:  Graeme B Mulholland; Caroline C Jeffery; Paras Satija; David W J Côté
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-06-20

3.  Orbital Pseudotumor: Uncommon Initial Presentation of IgG4-Related Disease.

Authors:  Teresa Carbone; Ricardo Azêdo Montes; Beatriz Andrade; Pedro Lanzieri; Luis Mocarzel
Journal:  Case Rep Rheumatol       Date:  2015-03-09

4.  Magnetic resonance imaging indicator of the causes of optic neuropathy in IgG4-related ophthalmic disease.

Authors:  Jing Li; Yan Zhang; Hang Zhou; Lei Wang; Zhenchang Wang; Hongyang Li
Journal:  BMC Med Imaging       Date:  2019-06-18       Impact factor: 1.930

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.